NCT03612791 2025-06-03
ATEZOLACC
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Completed
Clinical Trials
3 trialsNCT06055738 2023-09-28
Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
Tang-Du Hospital
Phase 2 Recruiting
NCT04884906 2021-05-13
Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown